JP2021530237A5 - - Google Patents
Info
- Publication number
- JP2021530237A5 JP2021530237A5 JP2021503011A JP2021503011A JP2021530237A5 JP 2021530237 A5 JP2021530237 A5 JP 2021530237A5 JP 2021503011 A JP2021503011 A JP 2021503011A JP 2021503011 A JP2021503011 A JP 2021503011A JP 2021530237 A5 JP2021530237 A5 JP 2021530237A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- item
- campylobacter
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024092422A JP2024116266A (ja) | 2018-07-17 | 2024-06-06 | Ｃａｍｐｙｌｏｂａｃｔｅｒの種に対する抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862699573P | 2018-07-17 | 2018-07-17 | |
| US62/699,573 | 2018-07-17 | ||
| PCT/US2019/042070 WO2020018584A2 (en) | 2018-07-17 | 2019-07-16 | Antibodies against campylobacter species |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024092422A Division JP2024116266A (ja) | 2018-07-17 | 2024-06-06 | Ｃａｍｐｙｌｏｂａｃｔｅｒの種に対する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530237A JP2021530237A (ja) | 2021-11-11 |
| JPWO2020018584A5 JPWO2020018584A5 (https=) | 2022-07-11 |
| JP2021530237A5 true JP2021530237A5 (https=) | 2022-07-11 |
Family
ID=67480448
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503011A Ceased JP2021530237A (ja) | 2018-07-17 | 2019-07-16 | Ｃａｍｐｙｌｏｂａｃｔｅｒの種に対する抗体 |
| JP2024092422A Pending JP2024116266A (ja) | 2018-07-17 | 2024-06-06 | Ｃａｍｐｙｌｏｂａｃｔｅｒの種に対する抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024092422A Pending JP2024116266A (ja) | 2018-07-17 | 2024-06-06 | Ｃａｍｐｙｌｏｂａｃｔｅｒの種に対する抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12297258B2 (https=) |
| EP (1) | EP3823727A2 (https=) |
| JP (2) | JP2021530237A (https=) |
| KR (1) | KR20210041557A (https=) |
| CN (1) | CN112867541B (https=) |
| AU (1) | AU2019306543A1 (https=) |
| BR (1) | BR112021000772A2 (https=) |
| CA (1) | CA3105222A1 (https=) |
| EA (1) | EA202190194A1 (https=) |
| IL (1) | IL280234A (https=) |
| MX (1) | MX2021000268A (https=) |
| SG (1) | SG11202013193XA (https=) |
| WO (1) | WO2020018584A2 (https=) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| CN100427603C (zh) | 1999-10-04 | 2008-10-22 | 麦迪卡格公司 | 调控外源基因转录的方法 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| EP1676862B1 (en) | 2003-09-24 | 2010-12-22 | Kyowa Hakko Kirin Co., Ltd. | Recombinant antibody against human insulin-like growth factor |
| JP2008501625A (ja) * | 2003-11-21 | 2008-01-24 | エース バイオサイエンシズ エー／エス | 表在Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉポリペプチド |
| GB0423681D0 (en) * | 2004-10-26 | 2004-11-24 | Sec Dep For Environment Food & | Vaccine and nucleic acids |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| KR20150073211A (ko) | 2012-10-24 | 2015-06-30 | 내셔날 리서치 카운실 오브 캐나다 | 항―캄필로박터 제주니 항체 및 그의 용도 |
| JP5916946B2 (ja) | 2013-03-11 | 2016-05-11 | 学校法人関西文理総合学園 | モノクローナルＩｇＡ抗体の製造方法 |
-
2019
- 2019-07-16 CN CN201980047394.7A patent/CN112867541B/zh active Active
- 2019-07-16 WO PCT/US2019/042070 patent/WO2020018584A2/en not_active Ceased
- 2019-07-16 EP EP19746385.4A patent/EP3823727A2/en not_active Withdrawn
- 2019-07-16 SG SG11202013193XA patent/SG11202013193XA/en unknown
- 2019-07-16 JP JP2021503011A patent/JP2021530237A/ja not_active Ceased
- 2019-07-16 MX MX2021000268A patent/MX2021000268A/es unknown
- 2019-07-16 AU AU2019306543A patent/AU2019306543A1/en active Pending
- 2019-07-16 US US17/260,966 patent/US12297258B2/en active Active
- 2019-07-16 CA CA3105222A patent/CA3105222A1/en active Pending
- 2019-07-16 KR KR1020217001975A patent/KR20210041557A/ko not_active Ceased
- 2019-07-16 EA EA202190194A patent/EA202190194A1/ru unknown
- 2019-07-16 BR BR112021000772-5A patent/BR112021000772A2/pt not_active IP Right Cessation
-
2021
- 2021-01-17 IL IL280234A patent/IL280234A/en unknown
-
2024
- 2024-06-06 JP JP2024092422A patent/JP2024116266A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021526022A5 (https=) | ||
| CN111620945A (zh) | 一种抗新型冠状病毒的单克隆抗体或其衍生体 | |
| AU2012269720B2 (en) | Antibodies against G-CSFR and uses thereof | |
| RU2019140602A (ru) | АНТИ-GARP-TGF-β-АНТИТЕЛА | |
| EP4036113B1 (en) | Humanized anti-il17a antibody and use thereof | |
| JP2024105229A5 (https=) | ||
| EP3656789A1 (en) | Antibody targeting interleukin 17a and preparation method and application thereof | |
| AU2023216791A1 (en) | Antibodies with improved stability to intestinal digestion | |
| WO2019061962A1 (zh) | 一种抗白介素17a的抗体、其制备方法和应用 | |
| CA3166346A1 (en) | Anti-angptl3 antibody and use thereof | |
| WO2018088850A2 (ko) | Cd40에 특이적으로 결합하는 항체 및 그의 용도 | |
| EP2822966B1 (en) | Treatment of mucositis with immunoglobulin a | |
| CN115038497A (zh) | TGF-β-RII结合蛋白质 | |
| JP2019518473A5 (https=) | ||
| CN114805570B (zh) | 一种抗人ace2单克隆抗体及其应用 | |
| TW202309076A (zh) | 用於治療α-突觸核蛋白病之抗體 | |
| IL277899B2 (en) | Methods and preparations for treating yellow fever | |
| JP2021530237A5 (https=) | ||
| WO2014061783A1 (ja) | クロストリジウム・ディフィシルの毒素に特異的なヒト抗体もしくはその抗原結合性断片 | |
| CN119119253A (zh) | 靶向结合腮腺炎病毒的抗体或其抗原结合片段 | |
| WO2014160098A2 (en) | Bordetella specific human recombinant antibodies and uses thereof | |
| JPWO2020018584A5 (https=) | ||
| WO2021258625A1 (zh) | 抗sar-cov-2(covid-19)全人源单克隆抗体及其制法与应用 | |
| WO2021248276A1 (zh) | 一种抗sar-cov-2抗体或其抗原结合片段及其应用 | |
| KR102087743B1 (ko) | IL-1beta에 특이적으로 결합하는 항체 및 그의 용도 |